Allergy and Infectious Diseases Research in Colorado
Allergy and Infectious Diseases Research (93.855) awarded $335 million to recipients in Colorado in 347 grants from fiscal 2021 to 2025, 1.5% of the program's national total. The Regents of the University of Colorado received the most, $168 million.
- Awarded in Colorado$335 million
- Awards347
- Share of the program1.5%
- Rank among states16th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 154 | $78.2 million |
| FY 2022 | 165 | $68.4 million |
| FY 2023 | 141 | $55.5 million |
| FY 2024 | 144 | $65.2 million |
| FY 2025 | 132 | $68.2 million |
Recipients in Colorado
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Regents of the University of Colorado | Colleges and universities | 182 | $168 million |
| Colorado State University | Colleges and universities | 62 | $83.8 million |
| National Jewish Health | Nonprofits | 22 | $58.2 million |
| The Regents of the University of Colorado | Colleges and universities | 17 | $13.4 million |
| Bolder Biotechnology Inc | Small businesses | 3 | $2.3 million |
| Peak Diagnostic Partners Inc | Small businesses | 2 | $2.3 million |
| University of Denver | Colleges and universities | 2 | $2.1 million |
| Sivec Biotechnologies, Inc. | Small businesses | 1 | $2.0 million |
| Trustees of the Colorado School of Mines | Colleges and universities | 2 | $817,602 |
| Solaris Vaccines, Inc. | Small businesses | 2 | $568,765 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Colorado?
$335 million from fiscal 2021 to 2025, across 347 awards. Colorado ranks 16th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Colorado?
The largest recipient is The Regents of the University of Colorado, with $168 million in 182 awards. Next are Colorado State University and National Jewish Health.
Can organizations in Colorado apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Colorado
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- 1332 State Innovation Waivers
- Special Education Grants to States
- Federal Transit Formula Grants